To date, around 60% of the world population has been protected by vaccines against SARS-
CoV-2, significantly reducing the devastating effect of the pandemic and restoring social …

In the acute phase of SARS-CoV-2 infection, varying degrees of clinical manifestations have
been noticed in patients. Some patients who recovered from the infection developed long …

Objectives To better define the spectrum of new-onset post-COVID-19 and post-COVID-19
vaccine inflammatory rheumatic diseases (IRD) from a large multicentric observational …

Still's disease is a rare inflammatory syndrome that encompasses systemic juvenile
idiopathic arthritis and adult-onset Still's disease, both of which can exhibit life-threatening …

As the number of reports of post-acute COVID-19 musculoskeletal manifestations is rapidly
rising, it is important to summarize the current available literature in order to shed light on …

COVID-19, the clinical syndrome produced by infection with SARS-CoV-2, can result in
multisystem organ dysfunction, including respiratory failure and hypercoagulability, which …

A comprehensive, up-to-date systematic review (SR) of the new-onset rheumatic immune-
mediated inflammatory diseases (R-IMIDs) following COVID-19 vaccinations is lacking …

Aim To analyze the clinical patterns of new‐onset inflammatory arthritis after COVID‐19
vaccination among patients without pre‐existing rheumatic or autoimmune diseases …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccination plays a crucial
role as pivotal strategy to curb the coronavirus disease-19 (COVID-19) pandemic. The …

Introduction Various vaccines for protection against COVID-19 were provided emergency
approval in late 2020 to early 2021. There is a scarcity of long-term safety data for many of …